Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Grifols ADR Representing One Non-Voting Ord Shs Class B GRFS

Healthcare Biotechnology
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale... see more

Recent & Breaking News (NDAQ:GRFS)

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

GlobeNewswire October 29, 2024

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

GlobeNewswire October 22, 2024

The Schall Law Firm Is Looking Into Grifols SA For Possible Securities Related Improprieties And Stockholders Are Invited To Reach Out

Accesswire September 6, 2024

Grifols S.A. May Have Committed Fraud And Investors Are Urged To Contact The Schall Law Firm About An Inquiry

Accesswire September 5, 2024

Grifols SA May Have Committed Securities Fraud And Investors With Losses Should Join The Schall Law Firm's Inquiry

Accesswire September 3, 2024

An Investigation Has Been Launched By The Schall Law Firm Into Grifols S.A.'s Possible Securities Law Violations And Shareholders Can Join

Accesswire September 2, 2024

Grifols SA Is Being Looked Into For Securities Fraud And Investors Should Reach Out To The Schall Law Firm About The Inquiry

Accesswire September 1, 2024

The Schall Law Firm Wants The Public To Participate In An Investigation Into Grifols S.A.'s Possible Securities Law Violations

Accesswire August 31, 2024

Grifols SA May Have Committed Securities Fraud And Stakeholders Are Invited To Join The Schall Law Firm's Inquiry

Accesswire August 30, 2024

The Schall Law Firm Is Looking Into Whether Grifols S.A. Violated Securities Regulations And Investors Are Urged To Reach Out

Accesswire August 29, 2024

An Investigation Has Been Launched Into Grifols SA For Securities Fraud And The Schall Law Firm Invites Shareholder Participation

Accesswire August 28, 2024

Grifols SA Is Being Inquired Into For Securities Violations And Investors Are Encouraged To Contact The Schall Law Firm

Accesswire August 27, 2024

The Schall Law Firm Urges Shareholders To Join An Investigation Into Grifols SA's Possible Securities Fraud

Accesswire August 26, 2024

An Inquiry Has Been Launched Into Grifols SA For Securities Law Infractions And The Schall Law Firm Is Seeking Investor Participation

Accesswire August 25, 2024

Grifols SA Is Being Investigated By The Schall Law Firm For Securities Fraud And Stakeholders Are Urged To Take Part

Accesswire August 24, 2024

The Schall Law Firm Has Launched An Inquiry Into Grifols SA For Potential Securities Violations And Stockholders Are Invited To Assist

Accesswire August 23, 2024

Grifols SA Is Being Investigated By The Schall Law Firm For Securities Fraud And Shareholders Are Encouraged To Help

Accesswire August 22, 2024

The Schall Law Firm Invites Investors In Grifols SA To Reach Out About The Company's Possible Securities Law Violations

Accesswire August 21, 2024

The Schall Law Firm Encourages Shareholders With Losses In Grifols SA To Contact The Firm About Potential Securities Law Violations

Accesswire August 20, 2024

Investors Are Invited To Reach Out To The Schall Law Firm About Grifols SA's Potential Securities Law Violations

Accesswire August 19, 2024